
Organovo Holdings ONVO
Quartalsbericht 2025-Q4
hinzugefügt 11.02.2026
Organovo Holdings Langfristiger Schuldenstrom 2011-2026 | ONVO
Langfristiger Schuldenstrom Jährlich Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 521 K | 506 K | 492 K | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 521 K | 492 K | 506 K |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Waters Corporation
WAT
|
31.1 M | $ 289.16 | -3.79 % | $ 17.2 B | ||
|
Exagen
XGN
|
1.23 M | $ 2.68 | -3.94 % | $ 57.8 M | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Sotera Health Company
SHC
|
5.76 M | $ 13.13 | -3.03 % | $ 3.73 B | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
BioNano Genomics
BNGO
|
697 K | $ 1.16 | 0.87 % | $ 6.32 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
21.6 M | $ 62.25 | -5.81 % | $ 24.3 B | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 23.53 | -4.74 % | $ 654 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 159.16 | -3.62 % | $ 7.89 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 195.51 | -1.33 % | $ 21.7 B | ||
|
OpGen
OPGN
|
174 K | - | -16.95 % | $ 1.54 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
PerkinElmer
PKI
|
589 M | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
383 K | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 8.7 | -4.92 % | $ 1.89 B | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 264.2 | -1.56 % | $ 22 B | ||
|
Psychemedics Corporation
PMD
|
1.05 M | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
218 K | $ 25.97 | -4.52 % | $ 33.7 M | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 16.78 | -3.95 % | $ 894 M | ||
|
Quotient Limited
QTNT
|
3.45 M | - | -11.32 % | $ 1.1 M | ||
|
Syneos Health
SYNH
|
43.1 M | - | - | $ 4.46 B | ||
|
Renalytix AI plc
RNLX
|
45 K | - | 5.66 % | $ 22.7 M | ||
|
VolitionRx Limited
VNRX
|
222 K | $ 0.2 | 1.87 % | $ 19.2 M | ||
|
Bioventus
BVS
|
3.3 M | $ 8.94 | -3.46 % | $ 596 M | ||
|
Co-Diagnostics
CODX
|
838 K | $ 4.4 | 101.83 % | $ 129 M | ||
|
Meridian Bioscience
VIVO
|
1.83 M | - | - | $ 1.49 B | ||
|
Danaher Corporation
DHR
|
199 M | $ 181.52 | -3.27 % | $ 129 B | ||
|
Surmodics
SRDX
|
1.04 M | - | - | $ 608 M | ||
|
ENDRA Life Sciences
NDRA
|
96.9 K | $ 4.29 | -6.54 % | $ 2.3 M |